Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
Recruiting · NCT07713940 · Interventional (participants receive a specific treatment) · Lead sponsor: University of California, San Diego
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- patients who meet the 2019 EULAR/ACR Classification Criteria for SLE
- patients who are on Cellcept or Myfortic for at least 3 months prior to screening
- patients with a score of ≥55 on the Patient Reported Outcomes Measurement Information System (PROMIS) Pain interference scale.
Exclusion criteria
- pregnant or lactating patients,
- patients with food allergy
- patients on antibiotics within 4 weeks of the screening
- patients that change the SLE therapy during the length of the study (12 weeks).
Where it is running
1 location listed across 1 US state.
- Altman Clinical Translational Research Insitute (UC San Diego) - La Jolla, California, United States